Study of Sunitinib Before and During Radiotherapy in Newly Diagnosed Biopsy-only Glioblastoma Patients
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
Sunitinib seems to be a promising treatment for the objective of this proposal: to evaluate
the clinical activity of Sunitinib as first line therapy in patients who have measurable
disease and to evaluate the safety of Sunitinib with radiation therapy.